| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 61.38B | 64.83B | 60.68B | 57.79B | 55.03B | 48.06B |
| Gross Profit | 19.74B | 21.11B | 19.44B | 19.17B | 17.54B | 14.97B |
| EBITDA | 4.02B | 4.45B | 4.16B | 4.61B | 3.48B | 1.18B |
| Net Income | 2.24B | 2.74B | 2.09B | 2.37B | 1.54B | 87.00M |
Balance Sheet | ||||||
| Total Assets | 42.59B | 45.30B | 41.84B | 43.41B | 40.02B | 37.82B |
| Cash, Cash Equivalents and Short-Term Investments | 8.12B | 9.27B | 8.09B | 9.68B | 7.14B | 6.04B |
| Total Debt | 1.12B | 450.00M | 540.00M | 424.00M | 425.00M | 481.00M |
| Total Liabilities | 7.58B | 8.35B | 6.66B | 8.65B | 7.34B | 6.19B |
| Stockholders Equity | 34.94B | 36.88B | 35.11B | 34.69B | 32.62B | 31.57B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 3.13B | 284.00M | 3.34B | 639.00M | -696.00M |
| Operating Cash Flow | 0.00 | 3.85B | 923.00M | 4.70B | 2.33B | 430.00M |
| Investing Cash Flow | 0.00 | -2.18B | -864.00M | -1.48B | -378.00M | -1.38B |
| Financing Cash Flow | 0.00 | -1.46B | -1.69B | -678.00M | -686.00M | -647.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | ¥29.41B | 11.96 | ― | 4.00% | 6.84% | 30.96% | |
76 Outperform | ¥143.18B | 6.66 | 10.46% | 2.35% | 2.55% | 72.25% | |
76 Outperform | ¥537.76B | 9.78 | 6.90% | 2.71% | 4.41% | 176.65% | |
74 Outperform | ¥78.67B | 21.16 | ― | 6.64% | 2.45% | 1.87% | |
69 Neutral | ¥62.49B | 15.41 | ― | 3.31% | 2.25% | 30.32% | |
63 Neutral | ¥96.87B | 19.03 | 7.53% | 3.01% | 5.17% | 20.88% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% |